Health Care & Life Sciences » Pharmaceuticals | Proteostasis Therapeutics Inc.

Proteostasis Therapeutics Inc.

Proteostasis Therapeutics Inc.
Stock Exchange NASDAQ Stock Market
EPS
 $1.58
Market Cap
 $50.46 M
Shares Outstanding
 51.1 M
Public Float
 34.13 M

Profile

Address
80 Guest Street
Boston Massachusetts 02135
United States
Employees -
Website http://www.proteostasis.com
Updated 07/08/2019
Proteostasis Therapeutics, Inc. engages in the research, development, and market of pharmaceutical products. Its medicines intend to treat cystic fibrosis, protein conformational and neurodegenerative diseases. The company was founded by William Balch, Jeffery W.

Financials

View All
Created with Highcharts 5.0.14Proteostasis Therapeutics Inc.Net Income. Fiscal year is January-December. All values USD Thousands.15 72015 72015 77215 77225 04025 04037 23237 23259 43259 43261 83261 832201320142015201620172018020k40k60k80k
Created with Highcharts 5.0.14Proteostasis Therapeutics Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.1 1411 1415 1505 1504 3124 3128 3848 3845 3415 3412 8402 84020132014201520162017201802k4k6k8k10k

Michael James Barrett
Chairman
Meenu Chhabra Karson
President, Chief Executive Officer & Director
View All

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.